Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 3Sbio, Alimera, Hansa, Hifibio, Catalyst, Kye, Revive, TLC.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Pharma, Cardiol, Cerecor, Dermavant, Mycovia, Novartis, Oncolytics, Oncology Venture, Outlook, Silverback.
New hires and promotions in the biopharma industry, including: Amylyx, Emergent, Geovax, Harpoon, Illumina, Immunovia, Innovation, Saniona, Starton, Vor.
Biopharmas in Asia-Pacific raising money in public or private financings, including: Bone Therapeutics, Connect Biopharmaceuticals, Opthea, Rnaimmune, Sirnaomics.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aligos, Astrazeneca, Carsgen, Kazia, Kimera Labs, Lidds, Merck, Opthea, Samsung Bioepis, Sorrento.